Introduction
0.25% [1, 2] . Therefore, careful follow-up of these lesions is warranted.
The recognition of the strong association between persistent infection with oncogenic human papillomavirus types and the subsequent development of cervical cancer has prompted the detection of HPV DNA as an alternative triage method [3] . A recent metaanalysis of the accuracy of HPV DNA detection for cervical intraepithelial neoplasia of grade 2 [5] . The sensitivity of the HC2 assay was 16% (ratio ϭ 1. 16 [6, 7] . [8] [9] [10] [11] . Recommendations for managing low-grade cytological abnormalities are not uniform, ranging from immediate colposcopy [10] to repeat cytology and referral if cytological abnormality is persistent [12] . The [10] , whereas others consider introducing it in screening programmes [13] . In Australia, reflex HPV testing to triage minor cytological abnormalities was not yet accepted, but this recommendation has been criticized [14] . In this new systematic review, we compare the HPV test positivity rate in women with equivocal and low-grade cytological abnormalities and examine how triage can be optimized by targeting different age groups.
Until recently, the recommended policy in case of cervical equivocal (borderline) or mild (low-grade) cytological abnormalities consisted of the repetition of the smear and referral for colposcopy if the lesion persists or progresses

Meanwhile, the ASCUS-LSIL triage study (AITS) has demonstrated superior performance of triage of women with ASCUS by testing for highrisk HPV types compared to repetition of the Pap smear or immediate colposcopy referral. The results from the ASCUS and LSIL triage study (ALTS), corroborated by meta-analytical work, provide the evidence for current recommendations for reflex hrHPV testing in case of atypical squamous cells of undetermined significance
utility of reflex hrHPV testing in case of LSIL or mild dyskaryosis is more controversial: it is not recommended in the most recent guidelines of the American Society for Colposocopy and Cervical Pathology
Methods
Methods for retrieving published reports regarding the accuracy of HPV triage of women with minor cervical abnormalities were described previously [4, 15] . Studies were included if the following three criteria were fulfilled: (1) [18] [19] [20] [21] .
We used a random effect model for pooling proportions [22] . Interstudy heterogeneity was assessed with Cochrane's Q-test [23] . The percentage of total variation across studies due to heterogeneity was evaluated by the I 2 measure [24] . Forest plots were drawn showing the variation of the HC2 test positivity rate among all studies together with the pooled measure [25, 26] . Subgroup meta-analyses were used to distinguish the respective cytological classification systems [27] . A random-effect was also used to pool the difference in test positivity rate between ASCUS/borderline and LSIL/mild dyskaryosis cases [28] . The change in HPV positivity rate by age category was assessed by a chi-square trend, which generalizes the Wilcoxon test to several ordered groups [29] . The influence of study characteristics on inter-study heterogeneity was explored using a multi-variate hierarchical meta-regression with the logit-transformed HPV positivity rate as the dependent variable [30] [31] [32] . Relative risks were computed from the coefficients of the metaregression using established formulas [33, 34] .
We used Stata, version 10.0 (Stata Corp., College Station, TX, USA), for statistical analysis [27, 35] .
Results
We identified 32 studies enrolling all together 26,311 women with a cytological report of ASCUS, ASC-US or borderline dyskaryosis that could be included in the meta-analysis [13, 16, . In 20 studies, high-risk HPV positivity could be derived for ASCUS defined according to TBS-1991 [13, 17, 37, 38, 41-44, 46, 50, 51, 59, 60, 64-66] [13] . [68, 69] . Nevertheless, the data of these studies and those from other included studies that provided values for higher thresholds [17, 46, 64] Table 2 ). The positivity rate decreased when the cutoff increased (-3 [78] [79] [80] . The ROC curve, in Fig. 4 Fig. 4 . Fig. 4 14-8. 64 . Ronco G, Cuzick J, Segnan N, Brezzi S, Carozzi F, Folicaldi S, Palma PD, Mistro AD, Gillio-Tos A, Giubilato P, Naldoni C, Polla E, Iossa A, Zorzi M, Confortini M,
